PROF. MARIO CHOJKIER, M.D.
Osteopathic Medicine at La Jolla Village Dr, San Diego, CA
License number
California C40587
Category
Osteopathic Medicine
Type
Gastroenterology
Address
Address
3350 La Jolla Village Dr, San Diego, CA 92161
Phone
(858) 552-8585
Personal information
See more information about MARIO CHOJKIER at radaris.comName
Address
Phone
935 Jeffrey Rd, Del Mar, CA 92014
12426 Ruette Alliante, San Diego, CA 92130
935 Jeffrey Rd, Del Mar, CA 92014
12531 El Camino Real, San Diego, CA 92130
Jeffrey Rd, Solana Beach, CA 92075
Organization information
See more information about MARIO CHOJKIER at bizstanding.comMario Chojkier MD
3350 Ln Jolla Vlg Dr, San Diego, CA 92161
Industry:
Internist
Phone:
(858) 552-8585 (Phone)
Mario Chojkier
Professional information
Dr. Mario Chojkier, San Diego CA - MD (Doctor of Medicine)
Specialties:
Gastroenterology
Address:
VA SAN DIEGO HEALTHCARE SYSTEM
3350 La Jolla Village Dr, San Diego 92161
(858) 552-8585 (Phone), (858) 552-7485 (Fax)
3350 La Jolla Village Dr, San Diego 92161
(858) 552-8585 (Phone), (858) 552-7485 (Fax)
Certifications:
Gastroenterology, 1987, Internal Medicine, 1985
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Buenos Aires / Faculty of Medicine
University of Buenos Aires / Faculty of Medicine
Mario Chojkier, San Diego CA
Specialties:
Internal Medicine, Gastroenterology
Work:
Va San Diego Healthcare System
3350 La Jolla Village Dr, San Diego, CA 92161
3350 La Jolla Village Dr, San Diego, CA 92161
Education:
Universidad De Buenos Aires (1970)
Treatment And Prevention Of Hepatic Disorders
US Patent:
6420428, Jul 16, 2002
Filed:
Nov 28, 2000
Appl. No.:
09/724600
Inventors:
Mario Chojkier - San Diego CA
Martina Buck - San Diego CA
Martina Buck - San Diego CA
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 31167
US Classification:
514618, 564182
Abstract:
The present invention provides new methods for the treatment of viral hepatitis C involving the administration of vitamin E and other compounds with antioxidant properties. Treatment with high doses of vitamin E is effective in treating chronic hepatitis C in patients refractory to interferon. In addition, new methods are described for the treatment of hepatic fibrosis and hepatic conditions manifesting hepatic fibrosis involving the administration of butylated hydroxytoluene and a metabolite of pentoxifylline, 1-[3-carboxypropyl]-3,7-dimethylxanthine. Furthermore, new methods are described for the treatment and prevention of hepatic disorders involving the use of 2,6-di-tert-butylphenol derivatives.
Compositions And Methods For Diagnosing Alzheimers Disease
US Patent:
6811988, Nov 2, 2004
Filed:
Oct 21, 2002
Appl. No.:
10/278181
Inventors:
Mario Chojkier - San Diego CA 92130
Martina Buck - San Diego CA 92117
Martina Buck - San Diego CA 92117
International Classification:
C12P 1900
US Classification:
435 72, 436503, 4241301, 4241781, 530300, 530402
Abstract:
The present invention provides methods and compositions for the diagnosis of Alzheimers disease. In particular, the present invention provides modified beta-amyloid peptides, antibodies that specifically bind to the modified beta-amyloid peptides, and methods for using these compositions in the diagnosis of Alzheimers disease, as well as methods to monitor treatment and/or disease progression of Alzheimers disease in patients. The present invention also provides compositions and methods useful in research involving amyloid precursor protein (APP) metabolism and Alzheimers disease.
Treatment And Prevention Of Hepatic Disorders
US Patent:
6369097, Apr 9, 2002
Filed:
Nov 28, 2000
Appl. No.:
09/724695
Inventors:
Mario Chojkier - San Diego CA
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 3139
US Classification:
514439, 514441, 514894
Abstract:
The present invention provides new methods for the treatment of viral hepatitis C involving the administration of vitamin E and other compounds with antioxidant properties. Treatment with high doses of vitamin E is effective in treating chronic hepatitis C in patients refractory to interferon. In addition, new methods are described for the treatment of hepatic fibrosis and hepatic conditions manifesting hepatic fibrosis involving the administration of butylated hydroxytoluene and a metabolite of pentoxifylline, 1-[3-carboxypropyl]-3,7-dimethylxanthine. Furthermore, new methods are described for the treatment and prevention of hepatic disorders involving the use of 2,6-di-tert-butylphenol derivatives.
Compositions And Methods For Diagnosing Alzheimers Disease
US Patent:
6495335, Dec 17, 2002
Filed:
Dec 7, 2000
Appl. No.:
09/731460
Inventors:
Mario Chojkier - San Diego CA 92130
Martina Buck - San Diego CA 92117
Martina Buck - San Diego CA 92117
International Classification:
G01N 3353
US Classification:
435 792, 435 71, 435 72, 435 793, 435 794, 435 795
Abstract:
The present invention provides methods and compositions for the diagnosis of Alzheimers disease. In particular, the present invention provides modified beta-amyloid peptides, antibodies that specifically bind to the modified beta-amyloid peptides, and methods for using these compositions in the diagnosis of Alzheimers disease, as well as methods to monitor treatment and/or disease progression of Alzheimers disease in patients. The present invention also provides compositions and methods useful in research involving amyloid precursor protein (APP) metabolism and Alzheimers disease.
Treatment Of Disease By Inducing Cell Apoptosis
US Patent:
8129349, Mar 6, 2012
Filed:
Aug 11, 2008
Appl. No.:
12/189526
Inventors:
Mario Chojkier - San Diego CA, US
Martina Buck - San Diego CA, US
Martina Buck - San Diego CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 38/07
US Classification:
514 219, 530330
Abstract:
The present invention relates generally to the treatment and prevention of diseases characterized by excess cell proliferation and/or activation. In particular, the present invention provides compositions and methods to suppress the activation and/or proliferation of various cells. In some preferred embodiments, the present invention provides compositions and methods to suppress the activation and/or proliferation of mesenchymally derived cells (including, but not limited to hepatic stellate cells), as well as cells with abnormal growth characteristics. In some particularly preferred embodiments, the present invention provides compositions and methods to inhibit or eliminate fibrosis. In alternative preferred embodiments, the present invention provides compositions and methods to induce fibrosis. In still further embodiments, the present invention provides methods and compositions to treat and/or prevent cancer.
Treatment And Prevention Of Hepatic Disorders
US Patent:
6147123, Nov 14, 2000
Filed:
Mar 23, 1999
Appl. No.:
9/274624
Inventors:
Mario Chojkier - San Diego CA
Dennis Carson - Del Mar CA
Dennis Carson - Del Mar CA
Assignee:
The Regents of the University of California - CA
International Classification:
A61K 3105, C07C 3904
US Classification:
514731
Abstract:
New methods are described for the treatment of viral hepatitis C involving the administration of vitamin E and other compounds with antioxidant properties. Treatment with high doses of vitamin E is effective in treating chronic hepatitis C in patients refractory to interferon. In addition, new methods are described for the treatment of hepatic fibrosis and hepatic conditions manifesting hepatic fibrosis involving the administration of butylated hydroxytoluene and a metabolite of pentoxifylline, 1-[3-carboxypropyl]-3, 7-dimethylxanthine.
Treatment And Prevention Of Hepatic Disorders
US Patent:
6218437, Apr 17, 2001
Filed:
Sep 21, 1999
Appl. No.:
9/400322
Inventors:
Mario Chojkier - San Diego CA
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 3105, C07C 3904
US Classification:
514731
Abstract:
The present invention provides new methods for the treatment of viral hepatitis C involving the administration of vitamin E and other compounds with antioxidant properties. Treatment with high doses of vitamin E is effective in treating chronic hepatitis C in patients refractory to interferon. In addition, new methods are described for the treatment of hepatic fibrosis and hepatic conditions manifesting hepatic fibrosis involving the administration of butylated hydroxytoluene and a metabolite of pentoxifylline, 1-[3-carboxypropyl]-3, 7-dimethylxanthine. Furthermore, new methods are described for the treatment and prevention of hepatic disorders involving the use of 2,6-di-tert-butylphenol derivatives.
Treatment And Prevention Of Hepatic Disorders
US Patent:
5922757, Jul 13, 1999
Filed:
Sep 30, 1996
Appl. No.:
8/723052
Inventors:
Mario Chojkier - San Diego CA
Assignee:
The Regents of the University of California - CA
International Classification:
A61K 31355, C07D31104
US Classification:
514458
Abstract:
New methods are described for the treatment of viral hepatitis C involving the administration of vitamin E and other compounds with antioxidant properties. Treatment with high doses of vitamin E is effective in treating chronic hepatitis C in patients refractory to interferon. In addition, new methods are described for the treatment of hepatic fibrosis and hepatic conditions manifesting hepatic fibrosis involving the administration of butylated hydroxytoluene and a metabolite of pentoxifylline, 1-�3-carboxypropyl!-3, 7-dimethylxanthine.